Literature DB >> 3304267

Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans.

T M Gudewicz, J T Mader, C P Davis.   

Abstract

The effects of hyperbaric oxygen (HBO) and antifungal agents on Candida albicans were studied. Growth curves at O2 tensions of 160 mm Hg, 900 mm Hg, and 1800 mm Hg for prolonged exposures showed no effect of pressure alone. There was a significant dose response to increasing O2 tension; growth inhibition occurred at 900 mm Hg O2 and killing at 1800 mm Hg O2. Minimum inhibitory concentrations (MIC) and minimum cidal concentrations (MCC) at 160 and 900 mm Hg O2 were done using amphotericin B, nystatin, clotrimazole, miconazole, ketoconazole and 5-fluorocytosine. MIC and MCC's were done with amphotericin B at 90-min exposures to 1800 mm Hg O2. There was no enhancement of MIC or MCC at 900 mm Hg O2. However, ketoconazole was ineffective at killing at 900 mm Hg O2 indicating a protective effect of HBO with this drug. Oxygen tensions of 1800 mm Hg for 90 min in the presence of amphotericin B showed an enhancement of both MIC and MCC. Closer quantitation of this effect upon the in vitro growth and survival of the organism showed an additive but not synergistic effect.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3304267

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  8 in total

1.  Hyperbaric Oxygen Reduces Aspergillus fumigatus Proliferation In Vitro and Influences In Vivo Disease Outcomes.

Authors:  Sourabh Dhingra; Jay C Buckey; Robert A Cramer
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

2.  Hyperbaric oxygen as an adjunct in zygomycosis: randomized controlled trial in a murine model.

Authors:  D M Barratt; K Van Meter; P Asmar; T Nolan; C Trahan; L Garcia-Covarrubias; S E Metzinger
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

3.  Hyperoxia and the antimicrobial susceptibility of Escherichia coli and Pseudomonas aeruginosa.

Authors:  K H Muhvich; M K Park; R A Myers; L Marzella
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

4.  Improvement of attention span and reaction time with hyperbaric oxygen treatment in patients with toxic injury due to mold exposure.

Authors:  N Ezra; K Dang; G Heuser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-10-27       Impact factor: 3.267

Review 5.  Mucormycosis of the Central Nervous System.

Authors:  Amanda Chikley; Ronen Ben-Ami; Dimitrios P Kontoyiannis
Journal:  J Fungi (Basel)       Date:  2019-07-08

Review 6.  COVID-19 associated mucormycosis: evolving technologies for early and rapid diagnosis.

Authors:  Rachel Samson; Mahesh Dharne
Journal:  3 Biotech       Date:  2021-12-06       Impact factor: 2.893

Review 7.  Bench-to-bedside review: oxygen as a drug.

Authors:  Haim Bitterman
Journal:  Crit Care       Date:  2009-02-24       Impact factor: 9.097

8.  Hyperbaric oxygen prevents early death caused by experimental cerebral malaria.

Authors:  Yara C Blanco; Alessandro S Farias; Uta Goelnitz; Stefanie C P Lopes; Wagner W Arrais-Silva; Bruna O Carvalho; Rogério Amino; Gerhard Wunderlich; Leonilda M B Santos; Selma Giorgio; Fabio T M Costa
Journal:  PLoS One       Date:  2008-09-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.